ÂÜÀòÂÒÂ×

Dr. Marc Schulte is a seasoned professional in the field of drug discovery services, currently serving as the Business Development Manager at Eurofins Discovery since April 2019. In this role, Dr. Schulte manages a multi-million dollar portfolio encompassing integrated services such as Pharmacology, ADME-Tox, Safety, Translational, and Chemistry Services, leading up to IND filing. Prior to this position, Dr. Schulte held various key roles including Key Account Manager at DiscoverX Corporation, Sales Manager at Indivumed GmbH and Cellectis, and Molecular Biology Sales Specialist at Thermo Fisher Scientific. Dr. Schulte's academic background includes a PhD from Christian-Albrechts-Universität zu Kiel, focusing on the structure and regulation of ADAM Metalloproteases, as well as a Diplom in Biology from Technische Universität Braunschweig.